Reaction: Brinzolamide to 1 product
- Reaction
- Reaction type
- demethylation
- Direction
- Major circulating metabolite?
- No
- Spontaneous?
- No
- Activity
- unknown
- References
- EMA Approved Drug Products: SIMBRINZA (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2@ for topical opththalmic use (May 2023) [Link]
- Comments
- Not Available
- Enzymes
Enzyme Km Vmax Role Cytochrome P450 3A4 Not Available Not Available implied Cytochrome P450 2A6 Not Available Not Available implied Cytochrome P450 2B6 Not Available Not Available implied Cytochrome P450 2C8 Not Available Not Available implied Cytochrome P450 2C9 Not Available Not Available implied
